The Biomarkers and Precision Medicine (BPM) Community is hosting a series of Open Scientific Discussions (OSDs) on Multi-omics in Drug Development. Please join us for the first OSD in the series hosted on May 30th, 12 - 1 pm ET:
Part 1: Multi-omics in Precision Medicine
· What are the factors that influence novel biomarker identification and characterization using multi-omic approaches?
· What are key considerations when choosing between the various multi-omic technologies?
· Case studies on the use of multi-omics to support precision medicine will be presented.
Discussion Leaders:
Matt Blatnik (AbbVie) and Christina Ebert (BMS)
Organized by: Jurre Kamphorst (Olaris), Iris Qiu (Novartis), Ayuko Ota-Selik and Jianing Zeng (BMS)
We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.
(Please remain on mute unless asking questions)
When: Thurs, May 30, 2024, 12 pm – 1 pm ET
Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893
You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 305-789-893
Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 305 789 893
Or dial directly: [email protected] or 67.217.95.2##305789893
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/305789893
Please feel free to share with colleagues who may be interested in this topic.
Thank you,
The AAPS BPM Community Leadership Team
#biomarker #precision_medicine #Proteomics #OpenScientificDiscussions #OSD #MachineLearning
------------------------------
Karen Quadrini, PhD
Director, Clinical Biomarkers
Prothena Biosciences
Brisbane, CA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------